Middle meningeal artery embolization for chronic subdural hematoma in elderly patients at high risk of surgical treatment
- Authors
- Jin Hoo Seok; Jong Hyun Kim; Taek Hyun Kwon; Joonho Byun; Won Ki Yoon
- Issue Date
- Mar-2023
- Publisher
- 대한뇌혈관외과학회
- Keywords
- Chronic subdural hematoma; Embolization; Middle meningeal artery; Craniotomy
- Citation
- Journal of Cerebrovascular and Endovascular Neurosurgery, v.25, no.1, pp 28 - 35
- Pages
- 8
- Indexed
- SCOPUS
KCICANDI
- Journal Title
- Journal of Cerebrovascular and Endovascular Neurosurgery
- Volume
- 25
- Number
- 1
- Start Page
- 28
- End Page
- 35
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/63950
- DOI
- 10.7461/jcen.2022.E2022.08.003
- ISSN
- 2234-8565
2287-3139
- Abstract
- Objective: The purpose of this study was to evaluate the effectiveness of middle meningeal artery embolization (MMAE) in elderly high-risk patients with symptomatic chronic subdural hematoma (CSDH) in terms of reduction in hematoma volume and recurrence rate. Methods: We retrospectively reviewed data prospectively collected from nine patients who underwent 13 MMAE for CSDH between June 2017 and May 2022. The volume of the subdural hematoma was measured using a computer-aided volumetric analysis program. Hematoma volume changes during the follow-up period were analyzed and clinical outcomes were evaluated. Results: The mean follow-up period was 160 days (range, 46−311 days). All procedures were technically successful and there were no procedure-related complications. Of the 13 MMAE, 84% (11 out of 13 hemispheres) showed mean 88% of reduction on follow-up volumetric study with eight cases of complete resolution. There was one refractory case with MMAE which had been performed multiple burr-hole trephinations, for which treatment was completed by craniotomy and meticulous resection of multiple pseudomembranes. There was no recurrent case during the follow-up period, except for refractory case. Conclusions: MMAE for CSDH in selected high-risk elderly patients and relapsed patients might be effective. Despite the small cohort, our findings showed a high rate of complete resolution with no complications. Further prospective randomized trials are warranted to evaluate its usefulness as a primary treatment option for CSDH.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Neurosurgery > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.